LAMAX | Dividend Growth Fund Class A | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Dividend Growth Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Dividend Growth Fund?

The Fund seeks to deliver total return by investing primarily in stocks of large U.S. companies that have a history of increasing their dividends.

HIGH-QUALITY UNIVERSE

Companies with consistent dividend growth are often market leaders with stable business models, strong balance sheets, and management teams committed to shareholders.

LOWER RISK PROFILE

Focusing on U.S. companies that have consistently grown their dividends often provides investors with an equity portfolio that has a lower risk profile than the broader market.

GROWTH AND RISING INCOME

A portfolio of consistent dividend growers may provide investors with long-term growth and rising income. Many of these companies have grown their dividends much faster than inflation.

Fund Basicsas of 02/29/2024

Total Net Assets
$3.89 B
Inception Date
12/27/2001
Dividend Frequency
Quarterly
Fund Gross Expense Ratio
0.92%
Fund Net Expense Ratio
0.92%
Number of Holdings
54
Minimum Initial Investment
$1,000+

Yield

12-Month Dividend Yield 1 as of 03/18/2024  

w/o sales charge 0.73%
w/ sales charge 0.69%

30-Day Standardized Yield 2 as of 02/29/2024  

0.54%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge 7.52% 23.85% 10.75% 12.59% 10.99% 8.99%
Lipper Category Avg. Equity Income Funds 3.37% 13.82% 8.83% 9.56% 8.56% -
S&P 500 Index 7.11% 30.45% 11.91% 14.76% 12.70% 9.02%
w/ sales charge 1.36% 16.74% 8.59% 11.26% 10.34% 8.70%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge 16.34% 16.34% 8.13% 13.07% 10.15% 8.70%
Lipper Category Avg. Equity Income Funds 11.40% 11.40% 8.70% 10.96% 8.27% -
S&P 500 Index 26.29% 26.29% 10.00% 15.69% 12.03% 8.74%
w/ sales charge 9.67% 9.67% 6.01% 11.74% 9.50% 8.41%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

Holdings as of 02/29/2024View Portfolio

Holding Assets
Microsoft Corp 8.9%
NVIDIA Corp 4.8%
Mastercard Inc 3.9%
Exxon Mobil Corp 3.6%
UnitedHealth Group Inc 2.9%
Apple Inc 2.9%
AbbVie Inc 2.8%
Eli Lilly & Co 2.7%
Lam Research Corp 2.4%
Accenture PLC 2.4%
% of Total Assets 37.4%

INVESTMENT TEAM

Darnell Azeez
Darnell Azeez, CFA

Partner, Portfolio Manager

21 Years of Industry Experience

Jeffrey Rabinowitz
Jeffrey Rabinowitz, CFA

Portfolio Manager

24 Years of Industry Experience

Subrata Ghose
Subrata Ghose, CFA

Portfolio Manager

28 Years of Industry Experience

Supported By 36 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

12-Month Dividend Yield 1 as of 03/18/2024  

w/o sales charge 0.73%
w/ sales charge 0.69%

30-Day Standardized Yield 2 as of 02/29/2024  

  Subsidized5 Un-Subsidized6
w/o sales charge 0.54% 0.54%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge 7.52% 23.85% 10.75% 12.59% 10.99% 8.99%
Lipper Category Avg. Equity Income Funds 3.37% 13.82% 8.83% 9.56% 8.56% -
S&P 500 Index 7.11% 30.45% 11.91% 14.76% 12.70% 9.02%
w/ sales charge 1.36% 16.74% 8.59% 11.26% 10.34% 8.70%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge 16.34% 16.34% 8.13% 13.07% 10.15% 8.70%
Lipper Category Avg. Equity Income Funds 11.40% 11.40% 8.70% 10.96% 8.27% -
S&P 500 Index 26.29% 26.29% 10.00% 15.69% 12.03% 8.74%
w/ sales charge 9.67% 9.67% 6.01% 11.74% 9.50% 8.41%

Fund Expense Ratio :

Gross 0.92%

Net 0.92%

Year Fund Returns S&P 500 Index
2023 16.34% 26.29%
2022 -13.53% -18.11%
2021 25.67% 28.71%
2020 15.50% 18.40%
2019 26.58% 31.49%
2018 -4.73% -4.38%
2017 19.09% 21.83%
2016 15.13% 11.96%
2015 -2.38% 1.38%
2014 11.56% 13.69%
2013 27.96% -
2012 13.05% -
2011 -0.23% -
2010 14.81% -
2009 23.21% -
2008 -27.29% -
2007 3.03% -
2006 14.78% -
2005 3.65% -
2004 16.72% -
Year Q1 Q2 Q3 Q4
2024 - - - -
2023 2.51% 5.93% -2.86% 10.30%
2022 -6.73% -12.38% -4.39% 10.67%
2021 4.27% 7.50% 0.12% 11.98%
2020 -19.86% 19.16% 9.55% 10.40%
2019 11.93% 3.96% 4.32% 4.27%
2018 -2.75% 1.25% 8.40% -10.74%
2017 4.37% 2.53% 3.38% 7.65%
2016 6.06% 4.89% 0.76% 2.71%
2015 -0.12% -2.21% -5.73% 6.01%
2014 1.52% 4.69% -1.43% 6.50%
2013 10.47% 1.27% 5.31% 8.61%
2012 10.90% -3.82% 5.76% 0.22%
2011 5.52% -0.22% -13.93% 10.10%
2010 4.78% -8.15% 10.21% 8.24%
2009 -5.29% 9.90% 12.47% 5.25%
2008 -8.66% -0.42% -9.07% -12.09%
2007 3.47% 4.17% -1.18% -3.26%
2006 2.32% 0.64% 3.27% 7.93%
2005 -1.04% 1.92% 2.63% 0.13%
2004 3.53% 1.67% 1.96% 8.76%
2003 -6.08% 11.96% 2.98% 12.47%
2002 7.39% -5.36% -13.24% 4.70%

Growth of $10,000 as of 02/29/2024

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 12/31/2023

  • As of the end of the period, the Fund’s largest active overweight relative to the S&P 500 Index is Mastercard Incorporated, a payment-processing corporation. We believe the company is attractively valued given the resiliency of the business model during an economic downturn, along with continued cross-border travel recovery in coming quarters.
  • The Fund is overweight relative to the benchmark in UnitedHealth Group Incorporated, a company that engages in the provision of health care coverage, software, and data consultancy services. We believe the company is attractively valued with a strong management team that has deployed cash wisely.
  • We expect the disinflationary environment of 2023 to continue into 2024, but the fact that interest rates are now well above the artificially low levels of the last decade demands a continued emphasis on quality to identify winners in the equity market. Operational and financial flexibility should enable well-positioned companies to gain market share, return excess cash to shareholders, and generate above-market returns over the business cycle.
  • In our view, more-profitable businesses have the agility to help them adapt to today’s increasingly uncertain environment, invest more strategically in their businesses, and seek out attractive M&A opportunities to enhance their existing businesses.

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 03/18/2024
$0
Dividend Frequency
Quarterly
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
12/26/2023 12/27/2023 12/27/2023 $0.04700 $19.42
09/27/2023 09/28/2023 09/28/2023 $0.03590 $17.82
06/28/2023 06/29/2023 06/29/2023 $0.03580 $18.10
03/29/2023 03/30/2023 03/30/2023 $0.03510 $17.11

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
03/27/2024 03/28/2024 03/28/2024
06/26/2024 06/27/2024 06/27/2024
09/24/2024 09/25/2024 09/25/2024
12/26/2024 12/27/2024 12/27/2024

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
12/18/2023 12/19/2023 $0.1096 - $0.1096 $19.46

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 03/18/2024

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $50,000 5.75% 5.00% $22.39
$50,000 to $99,999 4.75% 4.00% $22.15
$100,000 to $249,999 3.95% 3.25% $21.97
$250,000 to $499,999 2.75% 2.25% $21.70
$500,000 to $999,999 1.95% 1.75% $21.52
$1,000,000 to $5,000,000 0.00% 1.00% $21.10

EXPENSE RATIOas of 02/29/2024

Fund Gross Expense Ratio Fund Net Expense Ratio
0.92% 0.92%

Fund Documents

Fund Documents

0Documents selected
Portfolio Holdings 1Q
Publish Date:11/03/2015
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Fund Story
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The S&P 500® Index is widely regarded as the standard for measuring large cap U.S. stock market performance and includes a representative sample of leading companies in leading industries.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field